Document detail
ID

oai:pubmedcentral.nih.gov:1078...

Topic
Research
Author
Denu, Mawulorm K. I. Revoori, Ritika Buadu, Maame Araba E. Oladele, Oluwakemi Berko, Kofi Poku
Langue
en
Editor

BioMed Central

Category

AIDS Research and Therapy

Year

2024

listing date

2/9/2024

Keywords
study association cardiovascular hiv 0 medications antiretroviral factors associated p-value participants increased 95%ci hiv-related health risk aor
Metrics

Abstract

BACKGROUND: Human Immunodeficiency Virus (HIV) infection remains a public health concern in many countries.

The increased life expectancy in the post-Antiretroviral Therapy (ART) era has led to an increased risk of cardiovascular disease and death among Persons Living with HIV (PLHIV).

Hypertension remains a significant risk factor for cardiovascular disease among PLHIV.

Some studies have suggested associations between hypertension among PLHIV and HIV-related health factors.

OBJECTIVE: To determine the prevalence of hypertension among PLHIV on antiretroviral medications and examine its association with HIV-related health factors.

METHODS: A cross-sectional study was conducted among attendants at an adult HIV clinic.

362 study participants were selected by systematic sampling.

Data on hypertension diagnosis, HIV-related health factors, sociodemographic and other traditional cardiovascular risk factors were collected using a standardized questionnaire and patient chart review.

Multivariate logistic regression model was used to determine the association between hypertension and HIV-related factors, adjusting for other risk factors for hypertension.

RESULTS: The mean age of participants was 47.9 years and majority of participants were female (77.1%).

42% of study participants had been on antiretroviral medications for > 10 years.

The prevalence of hypertension was 17.4%.

Age > 50 years was associated with higher odds of hypertension (aOR: 3.75, 95%CI 1.68, 8.55, p-value: 0.002).

BMI in overweight and obese categories, and a history of comorbid medical conditions (diabetes, hyperlipidemia) were also associated with higher odds of hypertension (aOR: 3.

76, 95%CI 1.44, 9.81, p-value: 0.007), (aOR: 3.17, 95%CI 1.21, 8.32, p-value: 0.019) and (aOR: 14.25, 95%CI 7.41, 27.41, p-value: < 0.001) respectively.

No HIV-related health factors were associated with hypertension.

CONCLUSION: Hypertension was a common condition among PLHIV on antiretroviral medications.

No HIV-related health factors were associated with hypertension.

Traditional risk factors associated with hypertension were increased age > 50 years, increased BMI, and a history of comorbid medical conditions.

Denu, Mawulorm K. I.,Revoori, Ritika,Buadu, Maame Araba E.,Oladele, Oluwakemi,Berko, Kofi Poku, 2024, Hypertension among persons living with HIV/AIDS and its association with HIV-related health factors, BioMed Central

Document

Open Open

Share

Source

Articles recommended by ES/IODE AI

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
gravis myasthenia study clinical phase baseline improvement mg-adl 340 week trial placebo period mg maintenance qw